SB

Swati Bagla

Active Director Director DIN 08068910
DIN 08068910 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Swati Bagla

Data last updated:

Swati Bagla is a Director at Tracksun Pharmaceutical Limited (since 2018). The company operates in Pharma.

DIN 08068910
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2018
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tracksun Pharmaceutical Limited U74999DL2017PLC311554
Director15 Feb 20182017Active

Board colleagues of Swati Bagla

Directorship timeline

Open interactive timeline →
Tracksun Pharmaceutical Limited
Premium access

Shareholding and investment profile for Swati Bagla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swati Bagla

Swati Bagla currently holds 1 directorship: Tracksun Pharmaceutical Limited (Director, since 15 Feb 2018).

Swati Bagla was first appointed on 15 Feb 2018 as Director at Tracksun Pharmaceutical Limited.

The current boards of Swati Bagla's companies include Arvind Kumar (Tracksun Pharmaceutical Limited), Ashish Kumar (Tracksun Pharmaceutical Limited), Jyoti Verma (Tracksun Pharmaceutical Limited), Sanjay Kumar (Tracksun Pharmaceutical Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available